Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103843
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103843
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103843
Figure 5 Construction of nitric oxide synthase 1-mediated producer price index network in esophageal cancer.
CALM3: Calmodulin 3; CALML3: Calmodulin-like 3; CALML4: Calmodulin-like 4; CALML5: Calmodulin-like 5; CALML6: Calmodulin-like 6; DLG4: Discs large MAGUK scaffold protein 4; GRIN2B: Glutamate receptor, ionotropic, N-methyl D-aspartate 2B; NOS1: Nitric oxide synthase 1; NOS1AP: Nitric oxide synthase 1 adaptor protein; RASD1: Ras-related dexamethasone-induced 1; SNTA1: Syntrophin alpha-1.
- Citation: Xiao ZW, Zeng YC, Ji LT, Yuan JT, Li L. Nitric oxide synthase 1 inhibits the progression of esophageal cancer through interacting with nitric oxide synthase 1 adaptor protein. World J Gastrointest Oncol 2025; 17(4): 103843
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/103843.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.103843